Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid arthritis (RA) are unfounded, at least for U.S. military veterans ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid ...

The long-lasting inflammation can damage other parts of your body too, like your skin, eyes, lungs, and heart. While there is no known cure for RA, there are things you can do to help. Ask your ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

Complications of untreated RA include: permanent structural changes to the joint anemia lung damage Treatment can help prevent long-term issues. Long-term complications of lupus include heart and ...

AstraZeneca has decided not to pursue regulatory filings of its investigational rheumatoid arthritis drug ... of two investigational non-small cell lung cancer drugs, iniparib and otamixaban.

may be contributing to risks for rheumatoid arthritis and RA-associated interstitial lung disease, according to findings published in Arthritis & Rheumatology. Adverse events from disease ...

Patients in South Korea with vs without RA were associated with a greater risk of developing kidney cancer, but not other urological cancers.